316 related articles for article (PubMed ID: 37734381)
1. A cholinergic circuit that relieves pain despite opioid tolerance.
Sullere S; Kunczt A; McGehee DS
Neuron; 2023 Nov; 111(21):3414-3434.e15. PubMed ID: 37734381
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic modulation of descending pain control circuitry.
Umana IC; Daniele CA; Miller BA; Abburi C; Gallagher K; Brown MA; Mason P; McGehee DS
Pain; 2017 Oct; 158(10):1938-1950. PubMed ID: 28817416
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammatory pain prevents tolerance to the antinociceptive effect of morphine microinjected into the ventrolateral periaqueductal gray of the rat.
Mehalick ML; Ingram SL; Aicher SA; Morgan MM
J Pain; 2013 Dec; 14(12):1601-10. PubMed ID: 24161274
[TBL] [Abstract][Full Text] [Related]
4. Sex Differences in GABAA Signaling in the Periaqueductal Gray Induced by Persistent Inflammation.
Tonsfeldt KJ; Suchland KL; Beeson KA; Lowe JD; Li MH; Ingram SL
J Neurosci; 2016 Feb; 36(5):1669-81. PubMed ID: 26843648
[TBL] [Abstract][Full Text] [Related]
5. Blockade of Toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine.
Eidson LN; Murphy AZ
J Neurosci; 2013 Oct; 33(40):15952-63. PubMed ID: 24089500
[TBL] [Abstract][Full Text] [Related]
6. Persistent peripheral inflammation attenuates morphine-induced periaqueductal gray glial cell activation and analgesic tolerance in the male rat.
Eidson LN; Murphy AZ
J Pain; 2013 Apr; 14(4):393-404. PubMed ID: 23395474
[TBL] [Abstract][Full Text] [Related]
7. Change in functional selectivity of morphine with the development of antinociceptive tolerance.
Macey TA; Bobeck EN; Suchland KL; Morgan MM; Ingram SL
Br J Pharmacol; 2015 Jan; 172(2):549-61. PubMed ID: 24666417
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of the NOP receptor in the ventrolateral periaqueductal gray attenuates the development and the expression of tolerance to morphine-induced antinociception in rats.
Scoto GM; Aricò G; Iemolo A; Ronsisvalle G; Parenti C
Peptides; 2010 Apr; 31(4):696-700. PubMed ID: 20067813
[TBL] [Abstract][Full Text] [Related]
9. Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat.
Bobeck EN; Haseman RA; Hong D; Ingram SL; Morgan MM
J Pain; 2012 Aug; 13(8):799-807. PubMed ID: 22766006
[TBL] [Abstract][Full Text] [Related]
10. Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons.
Fyfe LW; Cleary DR; Macey TA; Morgan MM; Ingram SL
J Pharmacol Exp Ther; 2010 Dec; 335(3):674-80. PubMed ID: 20739455
[TBL] [Abstract][Full Text] [Related]
11. Activation of the P2X
Li P; Zhang Q; Xiao Z; Yu S; Yan Y; Qin Y
Mol Pain; 2018; 14():1744806918803039. PubMed ID: 30198382
[TBL] [Abstract][Full Text] [Related]
12. Activation of P2X7 receptors in the midbrain periaqueductal gray of rats facilitates morphine tolerance.
Xiao Z; Li YY; Sun MJ
Pharmacol Biochem Behav; 2015 Aug; 135():145-53. PubMed ID: 26054441
[TBL] [Abstract][Full Text] [Related]
13. A Regional and Projection-Specific Role of RGSz1 in the Ventrolateral Periaqueductal Grey in the Modulation of Morphine Reward.
Sakloth F; Sanchez-Reyes OB; Ruiz A; Nicolais A; Serafini RA; Pryce KD; Bertherat F; Torres-Berrío A; Gomes I; Devi LA; Wacker D; Zachariou V
Mol Pharmacol; 2023 Jan; 103(1):1-8. PubMed ID: 36310031
[TBL] [Abstract][Full Text] [Related]
14. Lack of Antinociceptive Cross-Tolerance With Co-Administration of Morphine and Fentanyl Into the Periaqueductal Gray of Male Sprague-Dawley Rats.
Bobeck EN; Schoo SM; Ingram SL; Morgan MM
J Pain; 2019 Sep; 20(9):1040-1047. PubMed ID: 30853505
[TBL] [Abstract][Full Text] [Related]
15. Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates.
Upadhya MA; Dandekar MP; Kokare DM; Singru PS; Subhedar NK
Neuropeptides; 2009 Aug; 43(4):303-14. PubMed ID: 19556004
[TBL] [Abstract][Full Text] [Related]
16. Reversal of sex differences in morphine analgesia elicited from the ventrolateral periaqueductal gray in rats by neonatal hormone manipulations.
Krzanowska EK; Ogawa S; Pfaff DW; Bodnar RJ
Brain Res; 2002 Mar; 929(1):1-9. PubMed ID: 11852025
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory mediators of opioid tolerance: Implications for dependency and addiction.
Eidson LN; Murphy AZ
Peptides; 2019 May; 115():51-58. PubMed ID: 30890355
[TBL] [Abstract][Full Text] [Related]
18. Ventrolateral orbital cortex oxytocin attenuates neuropathic pain through periaqueductal gray opioid receptor.
Taati M; Tamaddonfard E
Pharmacol Rep; 2018 Jun; 70(3):577-583. PubMed ID: 29679881
[TBL] [Abstract][Full Text] [Related]
19. The cholinergic agonist carbachol increases the frequency of spontaneous GABAergic synaptic currents in dorsal raphe serotonergic neurons in the mouse.
Yang C; Brown RE
Neuroscience; 2014 Jan; 258():62-73. PubMed ID: 24231737
[TBL] [Abstract][Full Text] [Related]
20. The functional antiopioid action of the ventrolateral periaqueductal gray nociceptin/orphanin FQ and nociceptin receptor system underlies DAMGO analgesic tolerance.
Parenti C; Scoto GM
Pharmacology; 2010; 86(3):138-44. PubMed ID: 20689345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
